Last reviewed · How we verify
NCT03660371
ILM Peeling in PDR Patients Undergoing PPV for VH
NA trial testing PPV/MP in Diabetic Retinopathy in 258 participants. Completed in 4 March 2020.
4 March 2020
Quick facts
| Lead sponsor | Rush Eye Associates |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 258 |
| Start date | 4 September 2018 |
| Primary completion | 4 March 2020 |
| Estimated completion | 4 March 2020 |
| Sites | 1 location across Mexico |
Drugs / interventions tested
- PPV/MP
- PPV without MP
Conditions studied
- Diabetic Retinopathy — all drugs for Diabetic Retinopathy →
- Macular Edema — all drugs for Macular Edema →
Sponsor
Rush Eye Associates
Who can join
Adults 18 to 85, any sex, with Diabetic Retinopathy or Macular Edema. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Subjects undergoing ILM peeling during vitrectomy will have better visual acuity and lower rates of DME to control subjects
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03660371
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of PPV/MP
Trials testing the same drug.
- NCT03660345 — PPV With Internal Limiting Membrane Peeling for Treatment-Naïve DME · Phase 3 · completed
Other recruiting trials for Diabetic Retinopathy
Currently open trials in the same condition.
- NCT07255326 — Effect of Omega-3 Fatty Acids on Eye Blood Vessels in Type 1 Diabetes · NA · recruiting
- NCT06782997 — Performance of the Electroretinogram, Performed and Interpreted by an Advanced Practice Nurse, in the Screening for Diab · recruiting
- NCT07002372 — Effect of Video Viewing on Intravitreal Injection Experience · NA · recruiting
- NCT06713720 — Remote Ischemic Conditioning for Non-Proliferative Diabetic Retinopathy · NA · recruiting
- NCT06892353 — AI-Powered DIY Screening System for Diabetic Retinopathy · NA · recruiting
Other Rush Eye Associates trials
Trials by the same sponsor.
- NCT04903301 — Patient Satisfaction With Contoura Vision Topography-Guided LASIK · NA · completed
- NCT04380077 — Gas Tamponade for Prevention of Postoperative Vitreous Hemorrhage in Diabetics · NA · unknown
- NCT04380064 — Internal Limiting Membrane Peeling in Proliferative Diabetic Retinopathy · NA · unknown
- NCT03660345 — PPV With Internal Limiting Membrane Peeling for Treatment-Naïve DME · Phase 3 · completed
- NCT03660384 — Silicone Oil Versus Gas in PDR Patients Undergoing Vitrectomy · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03660371 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Rush Eye Associates
- Last refreshed: 2 December 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03660371.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing